Table IV.
Groups | n | 30 min | 3 h | 6 h | 24 h |
---|---|---|---|---|---|
F | 25 | 2.25±0.63a,b | 2.73±0.66a,b | 2.39±0.50a,b | 1.27±0.54a |
D | 25 | 1.88±0.50a,b | 2.39±0.59a,b | 2.01±0.56a,b | 1.03±0.47a |
DF | 25 | 1.03±0.71a | 1.58±0.62a | 1.27±0.61a | 0.89±0.58a |
C | 25 | 3.49±0.64 | 4.77±0.75 | 3.73±0.68 | 2.31±0.73 |
Compared with Group C
P<0.01; compared with Group DF
P<0.01. VAS, visual analog scale; F, flurbiprofen axetil; D, dexmedetomidine; DF, dexmedetomidine combined with flurbiprofen axetil; C, saline control.